Evidence map›Paper›PMID 25644106›Full record

ArticleJournal of the American Society of Nephrology : JASN2015

Ultrasound Modulates the Splenic Neuroimmune Axis in Attenuating AKI.

Joseph C Gigliotti, Liping Huang, Amandeep Bajwa, Hong Ye, Eric H Mace, John A Hossack, Kambiz Kalantari, Tsuyoshi Inoue, Diane L Rosin, Mark D Okusa

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05685108 (Optimizing Ultrasound-induced Anti-inflammation in Human Subjects), which is not on this map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05685108 narecruitingnot on this mapstarted 2024, after this paper: background citation

Optimizing Ultrasound-induced Anti-inflammation in Human Subjects

TypeinterventionalSponsorUniversity of VirginiaRan2024 to 2026Enrolled40ConditionsHealthy SubjectsArmsUltrasound stimulation intensity, Ultrasound stimulation site
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 116 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Neuroimmune Control of Inflammation in Acute Kidney Injury and Multiorgan Dysfunction.Journal of the American Society of Nephrology : JASN · 2025
    Review
  6. Article
  7. Molecular Mechanisms of Sepsis-Associated Acute Kidney Injury.Journal of the American Society of Nephrology : JASN · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Organ Crosstalk: The Role of Spleen.Phenomics (Cham, Switzerland) · 2025
    Review
  14. Review
  15. Article
  16. New approaches to acute kidney injury.Clinical kidney journal · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Joseph C GigliottiDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine;
Liping HuangDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine;
Amandeep BajwaDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine;
Hong YeDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine;
Eric H MaceDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine;
John A HossackDepartment of Biomedical Engineering; and.
Kambiz KalantariDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine;
Tsuyoshi InoueDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine;
Diane L RosinDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine; Department of Pharmacology, University of Virginia Health System, Charlottesville, Virginia.
Mark D OkusaDepartment of Medicine, Division of Nephrology and Center for Immunity, Inflammation, and Regenerative Medicine; mdo7y@virginia.edu.
Immunité et Cancer · FRUniversity of Virginia Health System · US

Funding

Sphingolipids in Acute Kidney Injury and Disease ProgressionR01DK085259 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2023
$5.0M
Leukocyte Trafficking in Acute Renal FailureR01DK062324 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OKUSA, MARK DOUGLAS · 2003 to 2016
$4.4M
Kidney Disease and InflammationT32DK072922 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2006 to 2020
$2.6M
Sphingosine 1 phosphate receptors 1 and 3 as novel targets in transplantationK01DK091444 · NIDDK · UNIVERSITY OF VIRGINIA · PI BAJWA, AMANDEEP · 2012 to 2016
$579k
NIDDK NIH HHS K01 DK091444NIDDK NIH HHS K01-DK091444NIDDK NIH HHS R01 DK062324NIDDK NIH HHS R01-DK062324NIDDK NIH HHS R01 DK085259NIDDK NIH HHS R01-DK085259NIDDK NIH HHS T32 DK072922NIDDK NIH HHS T32-DK072922
6 · The paper itself

Abstract

We showed previously that prior exposure to a modified ultrasound regimen prevents kidney ischemia-reperfusion injury (IRI) likely via the splenic cholinergic anti-inflammatory pathway (CAP) and α7 nicotinic acetylcholine receptors (α7nAChR). However, it is unclear how ultrasound stimulates the splenic CAP. Further investigating the role of the spleen in ischemic injury, we found that prior splenectomy (-7d) or chemical sympathectomy of the spleen with 6-hydroxydopamine (6OHDA; -14d) exacerbated injury after subthreshold (24-minute ischemia) IRI. 6-OHDA-induced splenic denervation also prevented ultrasound-induced protection of kidneys from moderate (26-minute ischemia) IRI. Ultrasound-induced protection required hematopoietic but not parenchymal α7nAChRs, as shown by experiments in bone marrow chimeras generated with wild-type and α7nAChR(-/-) mice. Ultrasound protection was associated with reduced expression of circulating and kidney-derived cytokines. However, splenocytes isolated from mice 24 hours after ultrasound treatment released more IL-6 ex vivo in response to LPS than splenocytes from sham mice. Adoptive transfer of splenocytes from ultrasound-treated (but not sham) mice to naïve mice was sufficient to protect kidneys of recipient mice from IRI. Ultrasound treatment 24 hours before cecal ligation puncture-induced sepsis was effective in reducing plasma creatinine in this model of AKI. Thus, splenocytes of ultrasound-treated mice are capable of modulating IRI in vivo, supporting our ongoing hypothesis that a modified ultrasound regimen has therapeutic potential for AKI and other inflammatory conditions.

Indexed as

Ultrasonic TherapyAcute Kidney InjuryAnimalsMaleMiceMice, Inbred C57BLNeuroimmunomodulationSpleenacute renal failurecholinergic anti-inflammatory pathwayinflammationneuroimmunespleen

Identifiers

PMID25644106
PMCPMC4587697
OpenAlexW2071477860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.